World Theranostics Congress USA 2011 is North America’s leading conference on theranostic commercialization and partnership strategies for pharma, biotech and diagnostics

Peter Collins

GlaxoSmithKline

Ilhan Celik

Merck Serono

Eric Lai

Gen-Probe

Gregory F. Heath

Illumina

The World Theranostics Congress is North America’s number one dedicated companion diagnostics event. It is a three day strategic conference and a parallel exhibition. The conference features senior executives from pharma, biotech and diagnostics companies case studying scientific innovation and excellence, biomarkers, computational biology, partnership dynamics and much more…

How to survive regulatory submissions for
companion products
How to obtain reimbursement for products that stratify patient populations
How to improve business models and build profitable partnerships
How to optimize biomarker selection and maximize clinical utility for companion diagnostics
How to boost product pipelines by repurposing small molecules and strategic research investment

You’ll come away with great new ideas to implement and improve theranostics partnerships.

Dr. Elizabeth Gribble Walker, Director, Regulatory Strategy and Submission, Critcial Path Institute
Dr. Peter Collins, Vice President, Diagnostics, GlaxoSmithKline
John O'Connor, Executive Director, External Research and Development Affairs, Amgen
Dr. Ilhan Celik, Senior Director, Head of Biomarketer Strategy Oncology, Merck Serono
Dr. Eric Lai, Senior Vice President, Research and Development, Gen-Probe
Richard Ding, Chief Executive Officer, bioTheranostics
Dr. Gregory F. Heath, Senior Vice President and General Manager, Illumina